当前位置: 首页 > 期刊 > 《右江医学》 > 2025年第4期
编号:2384984
病毒性肝炎合并糖尿病患者终末期肝病影响因素分析
http://www.100md.com 2025年6月25日 右江医学 2025年第4期
    

    中图分类号:R587.1;R512.6 文献标志码:A DOI:10.3969/j. issn.1003-1383.2025.04.004

    Analysis of influencing factors of end-stage liver disease in patients withviralhepatitiscombinedwith diabetesmellitus

    LUO Yan 1 ,SONG Xiaolong',LI Nana’,MAO Yongkang 1 , LIU Dafeng 2 , ZHU Yanfeng 1? (1.School of Public Health,Chengdu Medical College,Chengdu 61o5OO,Sichuan,China; 2.Public Health Clinical Center ofChengdu,Chengdu 61oo61,Sichuan,China)

    【Abstract】ObjectiveTo explore the influencing factorsof end-stageliverdisease(ESLD)in patients with viral hepatitiscombied with diabetes melltus,and toprovideabasisforthepreventionanddelayof disease progression inESD. MethodsClinicaldataof patientswithviral hepatitiscombinedwithdiabetesmelitusadmittedtoPublic Health Clinical Center of Chengdu from October 27,2O18 to January25,2022 were retrospectivelyanalyzed.Thepatients were divided into casegroupandcontrol groupbasedon whethertheysuffredfromESLD ......

您现在查看是摘要页,全文长 16318 字符